FER

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA007641

Antibody CAB022464

Tissue

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Malignant cells generally showed weak nuclear immunoreactivity. Several malignant gliomas displayed moderate nuclear immunoreactivity.Most malignancies showed moderate immunoreactivity. Strong staining was observed in most thyroid, colorectal and endometrial but also in a few cases of pancreatic, liver, cervical cancers and gastric cancers.

Validation

Supportive: Two (or more) antibodies yielding dissimilar staining patterns which are consistent with available gene/protein characterization data
Supportive: Two (or more) antibodies yielding dissimilar staining patterns which are consistent with available gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected